1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy

Clinical trial NCT00153023 · COMPLETED

Trial details

NCT number: NCT00153023
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Nephropathies Hypertension

Start date: 2003-04-01
Primary completion: 2005-12-01
Enrollment: 885

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.